-
Cannabis Research Program At Ole Miss Approved, Funded By Mississippi Legislature
Wednesday, September 4, 2024 - 2:33pm | 561The Mississippi State Legislature passed legislation Tuesday to establish the Mississippi Medical Cannabis Research Program at the University of Mississippi, marking a significant step forward in the study of medical marijuana applications. Governor Tate Reeves (R) ratified the bill, which aims to...
-
DEA Ends 5-Decade Federal Monopoly On Research Cannabis Production, Approves Two Companies To Harvest Plants
Wednesday, January 5, 2022 - 12:41pm | 791The Drug Enforcement Administration (DEA) finally authorized two cannabis companies to harvest marijuana for research purposes, reported Marijuana Moment, ending a five-decade federal monopoly. Why is this important? Because a farm functioning as part of the ...
-
Congressional Committee Passes Bill To Enable Scientists To Undertake Research With Real Cannabis Products From Dispensaries
Thursday, June 10, 2021 - 11:22am | 529A bill that would enable researchers to analyze cannabis products from legal dispensaries was approved Thursday in the U.S. House committee, reports Marijuana Moment. What Happened This new provision is part of a large transit bill, which has now passed the House Transportation and...
-
Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids
Friday, December 4, 2020 - 11:17pm | 1198The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The rapid innovation and growth in biotechnology is being used to define, validate, and enhance therapeutic outcomes from cannabinoids....
-
Anti-Pot Legalization Group Pushes For More Marijuana Research
Friday, May 29, 2015 - 11:03am | 357Anti-marijuana legalization group Smart Approaches to Marijuana made an unexpected move this week and called for the Federal government to loosen the restrictions regarding scientific research into medical marijuana. The group, which is against the legalization of marijuana, says that more research...
-
In-Depth Look at ChromaDex and Its Clinical Results
Wednesday, June 13, 2012 - 5:41pm | 1895ChromaDex (OTC: CDXC) released positive clinical safety data today on its flagship ingredient, pTeroPure. ChromaDex is traded on the over-the-counter markets and saw heavy volume following the news, despite closing the session unchanged in price. Small companies are particularly complex and,...
-
Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?
Thursday, May 31, 2012 - 12:52pm | 1252Dear Vivus (NASDAQ: VVUS) investors: You are paying $2.5 billion for a company with zero profits in a market space valued at only $3.5 billion annually. Yes, the FDA advisory committee recommended Qnexa be granted approval in a 20-to-2 vote, but remember that Provenge had a unanimous safety vote...